Could cause temporary or reversible harm; serious harm is unlikely.
Labeling: Incorrect or Missing Lot and/or Exp Date: released with wrong expiry date as Feb.2027 instead of Jan.2027
| Brand name | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE |
| Generic name | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE |
| Active ingredient(s) | AMLODIPINE BESYLATE, BENAZEPRIL HYDROCHLORIDE |
| Distributed by / for | Lupin Pharmaceuticals, Inc., Naples, FL, 34108, United States |
| NDC | 68180-755-01 |
| Full product label | Amlodipine and Benazepril HCl Capsules USP 2.5 mg/10 mg, 100 Capsules bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL, 34108, United States, Manufactured by: Lupin Limited, Goa 103 722, INDIA, NDC 68180-755-01. |
| Recalling firm | Lupin Pharmaceuticals Inc. |
| Distribution | Nationwide in the US |
| Quantity | 7668 bottles |
| Recall initiated | 2025-07-02 |
| Report date | 2025-08-06 |
| Recall completed | — |
| Recall number | D-0542-2025 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Naples FL United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗